Phreesia, Inc. $PHR is Pale Fire Capital SE’s 6th Largest Position

Posted by on Sep 3rd, 2026

Pale Fire Capital SE grew its stake in Phreesia, Inc. (NYSE:PHR – Free Report) by 3.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,924,329 shares of the company’s stock after buying an additional 275,000 shares during the period. Phreesia accounts for 2.5% of Pale Fire Capital SE’s investment portfolio, making the stock its 6th largest holding. Pale Fire Capital SE owned about 14.44% of Phreesia worth $91,831,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in Phreesia in the second quarter valued at $72,234,000. Vanguard Group Inc. increased its position in Phreesia by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 5,744,326 shares of the company’s stock worth $97,194,000 after buying an additional 39,540 shares during the period. Granahan Investment Management LLC lifted its stake in Phreesia by 73.8% in the fourth quarter. Granahan Investment Management LLC now owns 2,399,613 shares of the company’s stock valued at $40,601,000 after buying an additional 1,018,987 shares during the last quarter. Franklin Resources Inc. lifted its stake in Phreesia by 28.8% in the fourth quarter. Franklin Resources Inc. now owns 2,000,082 shares of the company’s stock valued at $33,841,000 after buying an additional 446,890 shares during the last quarter. Finally, Nuveen LLC grew its position in Phreesia by 12.7% during the 4th quarter. Nuveen LLC now owns 1,875,725 shares of the company’s stock worth $31,737,000 after purchasing an additional 211,262 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Price Performance

Phreesia stock opened at $11.88 on Thursday. The company has a market cap of $734.30 million, a P/E ratio of 79.20 and a beta of 0.86. Phreesia, Inc. has a one year low of $7.77 and a one year high of $31.83. The business has a fifty day moving average of $11.19 and a two-hundred day moving average of $10.48. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76.

Phreesia (NYSE:PHR – Get Free Report) last posted its quarterly earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.06). The company had revenue of $129.46 million for the quarter, compared to analyst estimates of $129.06 million. Phreesia had a return on equity of 5.13% and a net margin of 1.85%.The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the company earned $0.01 earnings per share. As a group, analysts predict that Phreesia, Inc. will post 0.39 earnings per share for the current fiscal year.

More Phreesia News

Here are the key news stories impacting Phreesia this week:

  • Positive Sentiment: Phreesia generated positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, strengthening its balance sheet and supporting profitability expansion. Phreesia Announces Second Quarter Fiscal 2027 Results
  • Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with the $515 million analyst consensus, reducing the risk of a near-term outlook cut. The company also identified AccessOne as a potential multi-year growth driver. Phreesia maintains FY2027 revenue outlook
  • Positive Sentiment: Needham & Company issued a Buy rating, providing favorable analyst support for PHR following the earnings release. Phreesia Earns Buy Rating from Needham
  • Neutral Sentiment: Revenue reached $129.46 million, up 10.4% year over year and slightly above the $129.06 million consensus estimate, indicating continued growth but not a major top-line upside surprise. Phreesia fiscal second-quarter results
  • Negative Sentiment: Quarterly EPS was $0.03, below analyst expectations of approximately $0.09 to $0.11, although it improved from $0.01 in the prior-year quarter. The earnings shortfall may weigh on investor sentiment despite the company’s cash-flow progress. Phreesia Q2 earnings and revenues lag estimates

Analyst Ratings Changes

PHR has been the subject of a number of research reports. Citigroup reaffirmed a “market perform” rating on shares of Phreesia in a report on Friday, May 29th. Canaccord Genuity Group decreased their price target on Phreesia from $22.00 to $16.00 and set a “buy” rating for the company in a report on Thursday, May 28th. Weiss Ratings upgraded shares of Phreesia from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, July 20th. Truist Financial boosted their price objective on shares of Phreesia from $11.00 to $12.00 and gave the company a “hold” rating in a research note on Thursday, May 28th. Finally, DA Davidson reaffirmed a “buy” rating and issued a $14.00 target price on shares of Phreesia in a report on Thursday, May 28th. Nine investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Phreesia currently has a consensus rating of “Hold” and an average price target of $16.65.

View Our Latest Research Report on Phreesia

About Phreesia

(Free Report)

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

Featured Articles

Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR – Free Report).

Institutional Ownership by Quarter for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.